Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muzaffar H Qazilbash

Showing results (21-30 of 188) with videos related to

Pageof 19
Sort By:
Experimental Hematology|January 19, 2020
Panobinostat and venetoclax enhance the cytotoxicity of gemcitabine, busulfan, and melphalan in multiple myeloma cellsBenigno C Valdez, Yang Li, David Murray, et al.
Cancer|February 21, 2008
In-hospital complications of autologous hematopoietic stem cell transplantation for lymphoid malignancies: clinical and economic outcomes from the Nationwide Inpatient SampleJeffrey A Jones, Muzaffar H Qazilbash, Ya-Chen T Shih, et al.
Leukemia & Lymphoma|August 23, 2006
Risk factors for relapse after complete remission with high-dose therapy for multiple myelomaMuzaffar H Qazilbash, Rima M Saliba, Ana Aleman, et al.
Cancer|February 4, 2006
Second autologous or allogeneic transplantation after the failure of first autograft in patients with multiple myelomaMuzaffar H Qazilbash, Rima Saliba, Marcos De Lima, et al.
Acta Haematologica|April 26, 2003
Utility of a prognostic scoring system for allogeneic stem cell transplantation in patients with chronic myeloid leukemiaMuzaffar H Qazilbash, Marcel P Devetten, Jame Abraham, et al.
Leukemia & Lymphoma|May 22, 2014
Chromosome 8q24.1/c-MYC abnormality: a marker for high-risk myelomaIsabella C Glitza, Gary Lu, Rupin Shah, et al.
Expert Review of Cardiovascular Therapy|January 7, 2014
Cardiac amyloidosisSyed Wamique Yusuf, Amirreza Solhpour, Jose Banchs, et al.
Acta Haematologica|December 10, 2003
High-dose therapy and autologous stem cell transplantation in relapsed and refractory Hodgkin's disease: outcome based on a prognostic modelMuzaffar H Qazilbash, Marcel P Devetten, Jame Abraham, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 17, 2022
Stability of Captisol-enabled versus propylene glycol-based melphalan at room temperature and after refrigerationJitesh D Kawedia, Sumankalai Ramchandran, Xiaoqian Liu, et al.
Eclinicalmedicine|July 30, 2025
Therapeutic anti-cancer vaccines: a systematic review of prospective intervention trials for common hematological malignanciesDarshi Shah, Veer Shah, Karan Shah, et al.
Pageof 19

Showing results (21-30 of 188) with videos related to

Sort By:
Pageof 19
Experimental Hematology|January 19, 2020
Panobinostat and venetoclax enhance the cytotoxicity of gemcitabine, busulfan, and melphalan in multiple myeloma cellsBenigno C Valdez, Yang Li, David Murray, et al.
Cancer|February 21, 2008
In-hospital complications of autologous hematopoietic stem cell transplantation for lymphoid malignancies: clinical and economic outcomes from the Nationwide Inpatient SampleJeffrey A Jones, Muzaffar H Qazilbash, Ya-Chen T Shih, et al.
Leukemia & Lymphoma|August 23, 2006
Risk factors for relapse after complete remission with high-dose therapy for multiple myelomaMuzaffar H Qazilbash, Rima M Saliba, Ana Aleman, et al.
Cancer|February 4, 2006
Second autologous or allogeneic transplantation after the failure of first autograft in patients with multiple myelomaMuzaffar H Qazilbash, Rima Saliba, Marcos De Lima, et al.
Acta Haematologica|April 26, 2003
Utility of a prognostic scoring system for allogeneic stem cell transplantation in patients with chronic myeloid leukemiaMuzaffar H Qazilbash, Marcel P Devetten, Jame Abraham, et al.
Leukemia & Lymphoma|May 22, 2014
Chromosome 8q24.1/c-MYC abnormality: a marker for high-risk myelomaIsabella C Glitza, Gary Lu, Rupin Shah, et al.
Expert Review of Cardiovascular Therapy|January 7, 2014
Cardiac amyloidosisSyed Wamique Yusuf, Amirreza Solhpour, Jose Banchs, et al.
Acta Haematologica|December 10, 2003
High-dose therapy and autologous stem cell transplantation in relapsed and refractory Hodgkin's disease: outcome based on a prognostic modelMuzaffar H Qazilbash, Marcel P Devetten, Jame Abraham, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 17, 2022
Stability of Captisol-enabled versus propylene glycol-based melphalan at room temperature and after refrigerationJitesh D Kawedia, Sumankalai Ramchandran, Xiaoqian Liu, et al.
Eclinicalmedicine|July 30, 2025
Therapeutic anti-cancer vaccines: a systematic review of prospective intervention trials for common hematological malignanciesDarshi Shah, Veer Shah, Karan Shah, et al.
Pageof 19